The research team, led by Loren K. Barcenas of the Department of Health Behavior and senior author Leah Frerichs, conducted a systematic review of published systematic reviews, meta-analyses, and scoping reviews, following the PRISMA reporting guidelines that govern how evidence syntheses are identified, screened, and reported. The investigators searched three major biomedical databases, PubMed, Embase, and the Cumulative Index in Nursing and Allied Health Literature, for reviews published since 2014 that examined opioid impacts on pediatric populations. Two reviewers independently screened candidate articles and evaluated the methodological quality of each included review using the 11-item Joanna Briggs Institute criteria checklist, a standardized tool for judging how rigorously a review was conducted. From that process, twenty studies met the inclusion criteria and formed the evidentiary backbone of the umbrella review.

One sober methodological finding deserves attention before the substance: the average quality score of the included reviews was just 5.75 out of 11. That number signals to readers that while the collective evidence is broad, much of it rests on reviews with methodological limitations, whether in their search strategies, their assessment of individual studies, or their handling of bias. The authors are transparent about this constraint, and it frames the review’s conclusions as a map of what is known, and what is known less well, rather than a set of definitive effect estimates. For a field in which research funding and policy attention have historically flowed toward adult populations, that uneven evidence base is itself part of the story.

What the twenty reviews did document falls into four major outcome categories: physical health, neurodevelopment, psychosocial outcomes, and caregiving disruptions. The physical health effects are most visible in newborns. Infants exposed to opioids in the womb can develop neonatal abstinence syndrome, increasingly called neonatal opioid withdrawal syndrome, a constellation of withdrawal symptoms that can include irritability, feeding difficulties, tremors, and the need for extended hospitalization and pharmacologic treatment. These conditions have become a barometer of the crisis’s reach into delivery wards, and the umbrella review confirms that infants with prenatal opioid exposure are the most extensively studied pediatric group in the literature, with a substantial body of work documenting their immediate clinical course and early health trajectories.

Beyond the neonatal period, the evidence turns to neurodevelopment. Reviews synthesized in the analysis examined whether prenatal opioid exposure is associated with differences in cognitive performance, language development, motor skills, attention, and behavior as children grow. Attention deficit hyperactivity disorder emerges repeatedly in this literature as an outcome of concern, alongside broader questions about school readiness and executive function. The review’s authors are careful to note that isolating the effect of opioids from the confounding factors that travel with them, including prenatal exposure to other substances, maternal stress, poverty, and disrupted caregiving, remains a persistent methodological challenge. Still, the convergence of findings across multiple independent reviews supports the conclusion that opioid exposure can leave developmental traces that persist well past infancy.

The third and fourth domains extend the analysis beyond the exposed child to the family system. Psychosocial outcomes documented in the reviews include elevated risks for mental health difficulties, challenges with emotional regulation, and social adversity among children affected by their own exposure or by parental opioid misuse. Caregiving disruptions, meanwhile, capture a quieter but potentially profound harm: children whose parents struggle with opioid use disorder may experience instability in daily routines, foster care placement, kinship care arrangements, or the loss of a parent to overdose or incarceration. The umbrella review emphasizes that these indirect effects, transmitted through caregivers rather than through pharmacologic exposure, have received far less research attention than prenatal exposure, even though they affect a population that is at least as large.

That gap in the evidence is one of the review’s central messages. Effects were most extensively documented in infants with prenatal exposure, while research on parental opioid misuse affecting children, and on opioid misuse among adolescents and emerging adults themselves, remains comparatively thin. This is a striking asymmetry given that adolescents and young adults ages roughly 15 to 24 are among the groups at rising risk of initiating opioid misuse and developing opioid use disorder. The review explicitly flags adolescents and emerging adults as priority populations for future investigation, arguing that without better evidence, interventions and policies for these age groups will rest on extrapolation rather than on solid data.

Perhaps the most conceptually important finding concerns moderation. Across the synthesized literature, environmental factors, particularly socioeconomic status and the quality of caregiving, emerged as significant moderators of outcomes. In plain terms, the same pharmacologic exposure can lead to markedly different developmental trajectories depending on the resources, stability, and responsiveness of the child’s environment. This reframes opioid exposure not as biological destiny but as one risk operating within a web of protective and aggravating factors. It also offers a measure of hope: environments can be changed. Stable housing, responsive parenting support, early educational enrichment, and economic assistance are all modifiable, and the review’s findings suggest they may meaningfully alter the long-term outlook for affected children.

The authors translate this into a call for comprehensive early intervention that spans healthcare, education, and social services rather than treating opioid-related pediatric harm as a purely medical problem. For infants with neonatal opioid withdrawal syndrome, that means continued investment in evidence-based treatment and developmental follow-up. For young children affected by parental substance use, it means supporting caregivers through medications for opioid use disorder and family-centered services that keep families together when safe and possible. For adolescents, it means prevention and treatment systems designed for their developmental stage. The interconnected nature of the harms documented in the review, the authors argue, demands a correspondingly interconnected response, one that a single clinic or program cannot deliver alone.

Published as an open-access article with a permanent DOI, the review arrives at a moment when the crisis continues to evolve, with synthetic opioids reshaping exposure patterns in ways the included literature only partially captures. Its funding came from the William T. Grant Foundation, whose support runs through 2028, reflecting a funder focus on youth wellbeing. As a synthesis of syntheses, the paper does not offer a single headline statistic, and its authors would be the first to acknowledge that the quality of the underlying evidence averages barely above the midpoint of the assessment scale. What it does offer is a structured, honest account of how opioid misuse reverberates from the prenatal period through emerging adulthood, where the evidence is strong, where it is fragile, and where the next decade of research must go if children affected by the crisis are to receive interventions grounded in evidence rather than assumption.

Subject of Research: The effects of opioid misuse on fetal development, infants, children, adolescents, and emerging adults

Article Title: The impact of opioid misuse on fetal and pediatric populations: a systematic umbrella review

Article References: Barcenas, L. K., Kaz, L., Frerichs, L., & Hassmiller-Lich, K. (2026). The impact of opioid misuse on fetal and pediatric populations: a systematic umbrella review. Addiction Science & Clinical Practice. https://doi.org/10.1186/s13722-026-00715-w

Image Credits: AI Generated

DOI: 10.1186/s13722-026-00715-w

Keywords: opioid epidemic, pediatrics, fetal development, neonatal abstinence syndrome, neonatal opioid withdrawal syndrome, neurodevelopment, mental health, parental opioid misuse, caregiving disruption, umbrella review, early intervention, adolescent health

The opioid epidemic, which has persisted since the mid-1990s, has evolved from primarily affecting adults to increasingly impacting younger populations, raising multifaceted challenges. The study, “EMS Calls for Pediatric Patients Ages 11-18 years with Opioid Exposures using NEMSIS data,” scrutinizes EMS reports spanning from 2019 to 2023, distinguishing between middle school-aged children (11-13 years) and high school-aged adolescents (14-18 years). This stratification is crucial, revealing divergent patterns of opioid exposure that demand tailored clinical and preventative strategies.

The investigators observed a consistent rise in opioid-related EMS calls among pre-teens, with the number of calls more than doubling over the five-year period. Specifically, there was a stark increase from 255 calls in 2019 to 560 calls reported in 2023 within this subgroup. High school students experienced a different trajectory, with opioid exposure calls rising sharply through 2022, followed by a slight reduction in 2023. These variations suggest that while the epidemic continues to infiltrate younger cohorts with escalating intensity, some stabilization or early impacts of intervention efforts might be observed among older adolescents.

This dataset, sourced from NEMSIS, incorporates holistic emergency response details, including chief complaints identified via selected ICD-10 codes linked to opioid exposure and the administration of naloxone—the frontline opioid antagonist used in overdose rescues. The study’s methodological rigor, utilizing chi-square analyses and linear regression to evaluate trends and demographic distributions, reinforces the credibility of these concerning findings. Such granular data analysis paints a vivid picture of opioid-related health emergencies in pediatric populations, illuminating age-specific vulnerabilities and risk factors.

A fascinating demographic divergence emerges upon examining sex distribution within these age categories. In the younger cohort, females predominate EMS calls related to opioid exposure, accounting for approximately 61.1% of cases. Contrastingly, among high school youth, males constitute the majority of opioid-related emergency calls, representing nearly 59.4% of incidents. This gender disparity underscores the necessity for sex-specific approaches in both clinical evaluation and the development of public health interventions, recognizing that risk profiles and exposure scenarios might vary considerably by gender.

Another crucial dimension of the study is the assessment of acuity levels at presentation, revealing that younger children not only experience higher rates of opioid exposure but also present with more severe clinical states. Among middle school patients, nearly a quarter (24.5%) reach the EMS in a critical condition, compared to 15.7% in the older adolescent population. These acuity distinctions emphasize the intense physiological and developmental impacts opioids exert on younger users, possibly due to lower body mass, less physiological resilience, or differing substance use contexts, all of which necessitate urgent, age-appropriate medical responses and preventive measures.

Healthcare experts, including Dr. Sonia Lam, the study’s lead author and pediatric emergency medicine fellow, stress the urgency of addressing these trends. The increasing incidence of opioid exposures among pre-teens is a clear signal for the medical community and legislators to intensify efforts aimed at safeguarding this vulnerable demographic. Dr. Lam articulates a vision of targeted interventions informed by robust epidemiological data, recognizing that a one-size-fits-all approach may be inadequate amidst the complex landscape of pediatric substance use.

The implications of this research extend deeply into public health policy realms. Given the nuanced differences in opioid exposure patterns by age and sex, legislative authorities have an unprecedented opportunity to craft finely tuned policies that prioritize early detection, education, and intervention programs tailored to younger children, especially girls who appear disproportionately affected. Equally important is the enhancement of awareness among caregivers, educators, and healthcare providers, ensuring early recognition and swift response to opioid-related emergencies.

The study’s retrospective design harnessing the expansive NEMSIS database allows for robust longitudinal analysis, capturing emergent trends in a comprehensive manner unmatched by many prior investigations. NEMSIS’s nationwide scope, encompassing emergency responses from a vast spectrum of geographic and demographic contexts, affords a broad yet detailed understanding of pediatric opioid exposure, making this study a critical benchmark for future research and intervention planning.

Furthermore, the findings prompt critical reflection on the physiological and behavioral factors underpinning these trends. The higher acuity and increased prevalence among younger children could correlate with accidental ingestions, higher potency opioids, or distinct patterns of illicit substance availability in this age group. Additionally, the gender disparities might reflect social, psychological, or environmental influences that warrant deeper qualitative investigation to unravel underlying causes and inform more resilient prevention frameworks.

Clinically, these data demand heightened vigilance during pediatric emergency care. EMS professionals and emergency department teams must be equipped with protocols sensitive to the age-specific presentations and risks detailed in this study. Training should emphasize rapid recognition of opioid toxicity in children and adolescents, appropriate naloxone administration, and integration of post-rescue counseling and intervention to mitigate recurrence risk and facilitate connection to addiction treatment services.

Despite the gravity of these findings, it is important to acknowledge that the study’s data do not indicate a uniform crisis trajectory across all age groups. The observed reduction in calls among older adolescents post-2022 may reflect early impacts of education, policy shifts, or broader societal trends. These nuances highlight the dynamic nature of the opioid epidemic and the necessity for ongoing, data-informed surveillance to rapidly adjust public health responses as new patterns emerge.

Ultimately, this groundbreaking research offers both a warning and a roadmap for confronting the pediatric dimensions of the opioid crisis. The persistent rise in opioid exposure among middle school-aged children, coupled with high acuity presentations, spotlights a silent epidemic with potentially long-term ramifications for developmental health and societal well-being. Stakeholders in medicine, public health, and policymaking are called to action to expand age-appropriate, targeted interventions that address the unique vulnerabilities of children and adolescents, leveraging precise data to curb this troubling trend before its consequences become irrevocable.

Subject of Research: People
Article Title: Emergency Calls for Pediatric Opioid Exposure on Rise: New Research
News Publication Date: 26-Sep-2025
Keywords: Opioids, Drug safety, Pediatrics, Poisons